Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Pharmaceutical composition for treating dermatitis and eczema

A dermatitis and eczema composition technology, which is applied in the field of pharmaceutical compositions for the treatment of dermatitis and eczema, can solve the problems of inability to cure eczema, large side effects, and poor effect, and achieve the effects of improving allergic constitution, eliminating pathogenic bacteria, and avoiding repeated attacks

Inactive Publication Date: 2017-05-17
四川香龙丹医药科技有限公司
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the effect of Western medicine in treating eczema is not good. For the treatment of eczema, oral antihistamines are mostly used, and corticosteroids are mostly used for temporary suppression, such as oral western medicine, oral hormones, external solution lotions, emulsions, mud creams, oils Agents, ointments, emulsions, coatings, tinctures and plasters, etc., all of which can only relieve the symptoms of eczema, but cannot cure eczema, and have great side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] A pharmaceutical composition for treating dermatitis and eczema, comprising the following components in parts by mass: 15 parts of Scutellaria baicalensis, 12 parts of rhubarb, 10 parts of Sophora flavescens, 15 parts of white moss bark, 18 parts of poria cocos, and 8 parts of atractylodes rhizome.

[0020] The pharmaceutical composition also contains pharmaceutically acceptable auxiliary materials to prepare pharmaceutically acceptable external drug preparations. Wherein, the pharmaceutical preparation for external use is one of gel, ointment, liniment, film coating, lotion, spray and powder.

[0021] A preparation method of a pharmaceutical composition for the treatment of dermatitis eczema, comprising the following steps:

[0022] (1) Material preparation: take Scutellaria baicalensis, rhubarb, flavescens, bark of white moss, poria cocos and atractylodes atractylodes for subsequent use according to the parts by mass;

[0023] (2) Soak the weighed components in water...

Embodiment 2

[0026] A pharmaceutical composition for treating dermatitis and eczema, comprising the following components in parts by mass: 30 parts of Scutellaria baicalensis, 22 parts of rhubarb, 20 parts of Sophora flavescens, 8 parts of white moss bark, 10 parts of poria cocos, and 4 parts of atractylodes rhizome.

[0027] The pharmaceutical composition also contains pharmaceutically acceptable auxiliary materials to prepare pharmaceutically acceptable external drug preparations. Wherein, the pharmaceutical preparation for external use is one of gel, ointment, liniment, film coating, lotion, spray and powder.

[0028] A preparation method of a pharmaceutical composition for the treatment of dermatitis eczema, comprising the following steps:

[0029] (1) Material preparation: take Scutellaria baicalensis, rhubarb, flavescens, bark of white moss, poria cocos and atractylodes atractylodes for subsequent use according to the parts by mass;

[0030] (2) Soak the weighed components in water ...

Embodiment 3

[0033] A pharmaceutical composition for treating dermatitis and eczema, comprising the following components in parts by mass: 25 parts of Scutellaria baicalensis, 18 parts of rhubarb, 16 parts of Sophora flavescens, 10 parts of white moss bark, 14 parts of poria cocos, and 6 parts of atractylodes rhizome.

[0034] The pharmaceutical composition also contains pharmaceutically acceptable auxiliary materials to prepare pharmaceutically acceptable external drug preparations. Wherein, the pharmaceutical preparation for external use is one of gel, ointment, liniment, film coating, lotion, spray and powder.

[0035] A preparation method of a pharmaceutical composition for the treatment of dermatitis eczema, comprising the following steps:

[0036] (1) Material preparation: take Scutellaria baicalensis, rhubarb, flavescens, bark of white moss, poria cocos and atractylodes atractylodes for subsequent use according to the parts by mass;

[0037] (2) Soak the weighed components in water...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating dermatitis and eczema, prepared from the following components in parts by mass: 15-30 parts of scutellaria baicalensis, 12-22 parts of rhubarb, 10-20 parts of sophora flavescens, 8-15 parts of cortex dictamni, 10-18 parts of tuckahoe and 4-8 parts of rhizoma atractylodis. The pharmaceutical composition adopts a pure natural traditional Chinese medicine preparation, has no side effect on a human body, and fundamentally cures dermatitis and eczema through improving the allergic constitutions of patients.

Description

technical field [0001] The invention relates to the field of drugs for treating skin diseases, in particular to a pharmaceutical composition for treating dermatitis and eczema. Background technique [0002] Eczema and dermatitis are clinically common and frequently occurring skin diseases, among which acute eczema and dermatitis are more common. Because the disease often has strong itching, a lot of exudate, and is easy to relapse, especially long-term recurrent attacks and widespread skin lesions are more painful, it is one of the key subjects of clinical and basic research on dermatology at home and abroad. Modern medicine has proved that the pathological changes of eczema are intercellular edema (sponge formation) and intracellular edema in the epidermis, and telangiectasia, edema and mononuclear cell infiltration in the superficial dermis. From a clinical point of view, eczema is often difficult to find a clear cause. In recent years, it has been considered that eczema...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/75A61P17/00A61P31/04A61P31/10
CPCA61K36/076A61K36/284A61K36/489A61K36/539A61K36/708A61K36/75A61K2236/331A61K2300/00
Inventor 闫坤
Owner 四川香龙丹医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com